跳至主要内容
临床试验/ACTRN12620000197932
ACTRN12620000197932已完成未知

A randomised controlled trial comparing the clinical pregnancy per embryo transfer between an embryo that is selected by an artificial intellligence system (iDA) and and an embryo that is selected by an embryologist.

Vitrolife0 个研究点目标入组 1,066 人开始时间: 2020年2月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
Vitrolife
入组人数
1,066

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
21 Years 至 41 Years(—)
性别
Female

入选标准

  • Inclusion Criteria
  • 1)Women undergoing IVF or ICSI with controlled ovarian stimulation with gonadotrophins and the intention to treat by either transfer of a single fresh embryo on Day 5 or in case of a freeze all cycle, the first rewarmed embryo.
  • 2)Age: Up to and including the 42nd completed birthday on the day of randomization.
  • 3)Has at least two early blastocysts on Day 5

排除标准

  • Exclusion Criteria
  • 1)Treatment involving donated eggs
  • 2)Intention to perform any form of preimplantation genetic testing
  • 3)IMSI patients
  • 4)Previous participation in this RCT
  • 5)Where the cycle is carried out for fertility preservation.
  • 6)If a Day 2-4 transfer is planned
  • 7)Has a reduced likelihood of obtaining two early blastocysts on day 5 as evidenced by either:
  • An AMH level of <3pmol/L or AFC <5 (if available)

研究者

发起方
Vitrolife

相似试验